Medical Editor: John P. Cunha, DO, FACOEP
Aminosyn-HBC 7% (amino acid injection high branched chain) is a combination of amino acids used to prevent nitrogen loss or treat negative nitrogen balance in adults where (1) the alimentary tract by the oral, gastrostomy or jejunostomy route cannot or should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) nitrogen homeostasis is substantially impaired as with severe trauma or sepsis. Common side effects of Aminosyn-HBC 7% include:
- injection site reactions (skin redness, inflammation, warm sensation, and swelling)
- fever, and
The total dose of Aminosyn-HBC 7% depends upon daily protein requirements and the patient's metabolic and clinical response. Aminosyn-HBC 7% may interact with tetracycline. Tell your doctor all medications and supplements you use. During pregnancy, Aminosyn-HBC 7% should be used only if prescribed. Consult your doctor before breastfeeding.
Our Aminosyn-HBC 7% (amino acid injection high branched chain) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Reactions secondary to the administration technique or the solution include febrile response, infection at the injection site, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia.
Local reactions at the infusion site, consisting of a warm sensation, erythema, phlebitis and thrombosis have been reported with peripherally administered amino acid solutions, especially if other substances are also administered through the same site.
If electrolyte supplements are required during peripheral infusions, it is recommended that additives be administered throughout the day in order to avoid possible vein irritation. Irritating additive medications may require injection at another site and should not be added directly to the amino acid infusate.
Phosphorus deficiency may lead to impaired tissue oxygenation and acute hemolytic anemia. Relative to calcium, excessive phosphorus intake can precipitate hypocalcemia with cramps, tetany and muscular hyperexcitability.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
Read the entire FDA prescribing information for Aminosyn HBC 7% Sulfite Free (Amino Acid Injection High Branched Chain)
© Aminosyn HBC 7% Sulfite Free Patient Information is supplied by Cerner Multum, Inc. and Aminosyn HBC 7% Sulfite Free Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.